VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics announces its plans for financial growth, aiming to raise CDN$500,000 through a non-brokered private placement of units and up to CDN$3,000,000 via unsecured convertible debentures. The funds from these offerings are intended to support the company’s operational costs, focusing on sales, marketing, and general working capital needs.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
